Literature DB >> 24705628

Locoregional disease patterns in well-differentiated and dedifferentiated retroperitoneal liposarcoma: implications for the extent of resection?

William W Tseng1, John E Madewell, Wei Wei, Neeta Somaiah, Alexander J Lazar, Markus P Ghadimi, Aviad Hoffman, Peter W T Pisters, Dina C Lev, Raphael E Pollock.   

Abstract

BACKGROUND: Well-differentiated (WD)/dedifferentiated (DD) liposarcoma is the most common soft tissue sarcoma of the retroperitoneum. The frequency of distant metastasis is low and the major burden of disease is locoregional. We sought to define the patterns of locoregional disease to help guide surgical decision making.
METHODS: Data were collected from 247 patients with de novo or recurrent tumors treated at our institution from 1993 to early 2012. The number and location of tumors at both initial presentation and subsequent locoregional recurrence were determined by combined analysis of operative dictations and radiologic imaging.
RESULTS: Thirty-four percent of patients had multifocal locoregional disease (two or more tumors) at initial presentation to our institution, including 9 % who had tumors at synchronous remote retroperitoneal sites. The impact of multifocal disease on overall survival was dependent on histologic subtype (WD vs. DD) and disease presentation (de novo vs. recurrence) at the time of resection. Among patients with initial unifocal disease, 57 % progressed to multifocal locoregional disease with subsequent recurrence, including 11 % with new tumors outside of the original resection field. No clinicopathologic or treatment-related variable, including the type or extent of resection, was predictive of either multifocal or 'outside field' progression.
CONCLUSIONS: Multifocal disease is common in patients with WD/DD retroperitoneal liposarcoma, and tumors can also develop at remote, locoregional sites. Surgical resection remains the primary method of locoregional control in this disease; however, the aggressiveness of resection should be individualized, with consideration of both tumor and patient-related factors.

Entities:  

Mesh:

Year:  2014        PMID: 24705628     DOI: 10.1245/s10434-014-3643-4

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  32 in total

1.  Huge retroperitoneal liposarcoma with renal involvement requires nephrectomy: A case report and literature review.

Authors:  Jun Yang; Yue Zhao; Chun Hua Zheng; Qian Wang; Xue Yu Pang; Tian Wang; Jiao Jiao Ma
Journal:  Mol Clin Oncol       Date:  2016-09-14

2.  A novel nomogram for predicting local recurrence-free survival after surgical resection for retroperitoneal liposarcoma from a Chinese tertiary cancer center.

Authors:  Guoqiang Xue; Zhen Wang; Chengpeng Li; Ang Lv; Xiuyun Tian; Jianhui Wu; Hui Qiu; Chunyi Hao
Journal:  Int J Clin Oncol       Date:  2020-10-17       Impact factor: 3.402

3.  Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group.

Authors: 
Journal:  Ann Surg Oncol       Date:  2016-08-01       Impact factor: 5.344

4.  A retrospective, single-center cohort study on 65 patients with primary retroperitoneal liposarcoma.

Authors:  Yi-Xi Wu; Jun-Yan Liu; Jia-Jia Liu; Peng Yan; Bo Tang; You-Hong Cui; Yong-Liang Zhao; Yan Shi; Ying-Xue Hao; Pei-Wu Yu; Feng Qian
Journal:  Oncol Lett       Date:  2017-12-05       Impact factor: 2.967

5.  Paraneoplastic Syndrome Associated with the Retroperitoneal Dedifferentiated Liposarcoma: an Atypical Presentation and Review of the Literature.

Authors:  Jeewan Ram Vishnoi; Ankit Jain; Sanjeev Misra; Puneet Pareek; Meenakshi Rao; Binit Sureka; Ashok Puranik
Journal:  Indian J Surg Oncol       Date:  2019-08-13

6.  Concomitant organ resection does not improve outcomes in primary retroperitoneal well-differentiated liposarcoma: A retrospective cohort study at a major sarcoma center.

Authors:  Naruhiko Ikoma; Christina L Roland; Keila E Torres; Yi-Ju Chiang; Wei-Lien Wang; Neeta Somaiah; Gary N Mann; Kelly K Hunt; Janice N Cormier; Barry W Feig
Journal:  J Surg Oncol       Date:  2017-12-11       Impact factor: 3.454

7.  Surgical outcome and patterns of recurrence for retroperitoneal sarcoma at a single centre.

Authors:  H D J Hogg; D M Manas; D Lee; P Dildey; J Scott; J Lunec; J J French
Journal:  Ann R Coll Surg Engl       Date:  2016-02-14       Impact factor: 1.891

8.  Combined Modality Management of Retroperitoneal Sarcomas: A Single-Institution Series of 121 Patients.

Authors:  Andrew J Bishop; Gunar K Zagars; Keila E Torres; Kelly K Hunt; Janice N Cormier; Barry W Feig; B Ashleigh Guadagnolo
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-05-02       Impact factor: 7.038

Review 9.  Liposarcoma: molecular targets and therapeutic implications.

Authors:  Kate Lynn J Bill; Lucia Casadei; Bethany C Prudner; Hans Iwenofu; Anne M Strohecker; Raphael E Pollock
Journal:  Cell Mol Life Sci       Date:  2016-05-12       Impact factor: 9.261

10.  Hibernation of masses suspected to be remnant tumors after surgical resection of retroperitoneal liposarcoma is related to improved overall survival.

Authors:  Jinsoo Rhu; Kyo Won Lee; Jae Berm Park; Sung Joo Kim
Journal:  Int J Clin Oncol       Date:  2018-01-19       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.